BMA
Overvalued by 98% based on the discounted cash flow analysis.
Market cap | $3.70 Billion |
---|---|
Enterprise Value | $-1,662,187,880,317.00 |
Dividend Yield | $0.76 (2.07%) |
Earnings per Share | $5090.6 |
Beta | 0.69 |
Outstanding Shares | 63,941,300 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 52.67 |
---|---|
PEG | -62.92 |
Price to Sales | 0.0 |
Price to Book Ratio | 0.0 |
Enterprise Value to Revenue | -0.38 |
Enterprise Value to EBIT | 313.92 |
Enterprise Value to Net Income | 15 |
Total Debt to Enterprise | -0.29 |
Debt to Equity | 0.11 |
No data
No data